Bruker Corporation (BRKR)
Goldman Sachs Healthcare Conference
June 5, 2012 5:00 p.m. EDT
Isaac Ro – Goldman Sachs, Analyst
Stacey Desrochers – Burker Corporation, IR Director
Okay, let’s get started here. Thanks for joining us here after lunch. I'm Isaac Ro, analyst here at Goldman. And I'm happy to have Stacey Desrochers from Bruker here to talk about the company.
And for those of you who are not familiar, the company has actually had a very busy start to the summer here. You had a big showing at the ASMS Conference. You had your first-ever investor meeting last week in New York. So there’s a lot of new stuff going on, and the stock’s had a pretty good run here with lots of improvements to the franchise over the last couple of years.
So, certainly, happy to take any questions throughout the course of the next 30 or 40 minutes. If you have them, please just raise your hand.
And with that as backdrop, let me just start by saying, thanks for coming, and feel free to give us a couple minutes update for the takeaways on the analyst meeting, if you like, and the key areas of focus for the balance of the year.
So, Bruker Corporation is a life science tools company. As Isaac said, we had our first Analyst Day ever last Friday in New York. It was well-attended, webcast and out there for folks if you want to listen to it. But we highlighted technologies and the new businesses that we acquired in 2010.